Sept 7 (Reuters) - AstraZeneca Plc Chief Executive
Pascal Soriot said booster COVID vaccine doses may not be needed
for everyone in Britain and rushing into a nationwide rollout of
third doses risks piling extra pressure on the National Health
Service (NHS), the Telegraph reported on Tuesday.
"We need the weight of the clinical evidence gathered from
real world use before we can make an informed decision on a
third dose," Soriot wrote in the newspaper.
He further said that "mobilising the NHS for a boosting
program that is not needed would potentially add unnecessary
burden on the NHS over the long winter months."
(Reporting by Aishwarya Nair in Bengaluru
Editing by Chris Reese)